Home > Specialists > Medical Oncology > Dr. Yingyi Wang (王颖轶)
Specialty & Clinical Focus:
Chief Physician and medical oncologist at Peking Union Medical College Hospital (PUMCH) in Beijing, with a clinical focus on early- to late-stage lung cancer, precision medicine, pulmonary nodule diagnosis, targeted therapy, immunotherapy and complex oncology management.
Professional Title & Qualifications:
Chief Physician,
Professor,
MD
Hospital & Department：
Peking Union Medical College Hospital (PUMCH) – Department of Medical Oncology
(Note: PUMCH is consistently ranked as the #1 hospital in China)
(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)
Dr. Yingyi Wang (王颖轶) - Medical Oncology Specialist
Personal Biography
Dr. Yingyi Wang is a Chief Physician and Professor in the Department of Medical Oncology at Peking Union Medical College Hospital (PUMCH) in Beijing. He holds a doctoral degree in Clinical Medicine from Peking Union Medical College.
His clinical work focuses on personalized treatment for early- to late-stage lung cancer, precision medicine, targeted therapy, immunotherapy and the differential diagnosis of pulmonary nodules. At PUMCH, he established a precision diagnosis and treatment system and developed a targeted combination therapy model for advanced lung cancer.
Alongside his clinical practice, Dr. Wang has published nearly 50 papers in SCI and core journals as first or corresponding author and has led multiple national and provincial research projects. His combined clinical and research background is relevant to patients seeking specialist input on complex lung cancer pathways or pulmonary nodule evaluation.
Why Choose Dr. Yingyi Wang (via MedBridgeNZ)
Dr. Yingyi Wang combines senior medical oncology practice at PUMCH with a focused interest in precision treatment for early- to late-stage lung cancer and the differential diagnosis of pulmonary nodules. His experience in targeted therapy, immunotherapy and complex oncology management is particularly relevant for patients seeking specialist input on an existing diagnosis, prior treatment history or unresolved questions before travelling to Beijing.
A well-prepared remote specialist review can help patients obtain clearer expert input before deciding whether an in-person pathway should be pursued. Diagnostic reports, imaging, prior treatment records and a focused question list should be organized in advance so the case can be reviewed efficiently.
Precision oncology focus: Personalized lung cancer pathways involving targeted therapy, immunotherapy and ongoing clinical monitoring.
Pulmonary nodule expertise: Specialist evaluation of benign-versus-malignant differential diagnosis and related next-step questions.
PUMCH clinical setting: Senior oncology practice within the Department of Medical Oncology at PUMCH in Beijing.
Pre-Travel Case Review & Specialist Liaison
Before committing to international travel, MedBridgeNZ coordinates a structured pre-travel case review pathway with Dr. Yingyi Wang at PUMCH. We organize diagnostic reports, imaging, prior treatment history and the patient’s key questions; coordinate translation where required; and complete secure, client-authorized document transfer and appointment communication with the relevant hospital office.
Once the review pathway is confirmed, Dr. Wang will review the submitted records and provide a specialist opinion, recommendations and responses to the patient’s questions. MedBridgeNZ then coordinates follow-up communication and practical travel planning, helping the patient decide whether to pursue an in-person oncology pathway in Beijing with clearer specialist input.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Yingyi Wang
Areas of Expertise
Lung Cancer Precision Treatment: Personalized protocols for early, middle, and late-stage lung cancer using targeted therapy and immunotherapy.
Pulmonary Nodule Diagnosis: Expert screening and differentiation of benign and malignant nodules.
Immune Function Monitoring: Advanced dynamic monitoring to guide cancer treatment strategies.
Complex Oncology Management: Comprehensive care aimed at extending survival (averaging 5-10 years for many patients) and improving life quality.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 4.9/5.0 Overall Rating
* Treatment Pathway Satisfaction:
4.9/5.0
* Communication & Professionalism:
4.9/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
8,500 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2022.10 – Present: Chief Physician, Department of Medical Oncology, Peking Union Medical College Hospital (PUMCH).
2016.10 – 2022.09: Associate Chief Physician, Department of Medical Oncology, PUMCH.
2009.11 – 2016.09: Attending Physician, Department of Medical Oncology, PUMCH.
2008.09 – 2009.10: Chief Resident, Department of Medical Oncology, PUMCH.
2007.09 – 2008.08: Chief Resident, Department of Internal Medicine, PUMCH.
2003.08 – 2007.08: Resident, Department of Internal Medicine, PUMCH.
Education & Training
Doctoral degree in Clinical Medicine, Peking Union Medical College.
Awards & Honors
2024: "PUMCH Star Plan" Key Project Grant.
2022: Awarded title of "Outstanding Teacher" at Peking Union Medical College Hospital.
2021: First Prize, PUMCH Medical Achievement Award.
2017 & 2021: Second Prize, PUMCH Medical Achievement Award.
2018: National First Prize, University Micro-course Teaching Competition (Topic: "Ten-Year Evolution of Lung Cancer Treatment").
Teaching Awards: Recipient of two provincial/ministerial-level key teaching awards.
Academic & Professional Memberships
Expert Reviewer: Beijing Municipal Science & Technology Commission.
Vice Chairman: Professional Committee on Immunotherapy Adverse Event Management, Beijing Cancer Prevention Society.
Vice Chairman: Lung Cancer Diagnosis and Treatment Expert Committee, Beijing Health Promotion Association.
Standing Committee Member: Health Science Popularization Working Committee, Beijing Association of Integrative Medicine.
Editorial Board Member: Chinese Journal of Clinical Nutrition (6th Editorial Board).
Research & Publications
Publications: Published nearly 50 papers in SCI and core journals as first or corresponding author, with a cumulative Impact Factor (IF) of nearly 200.
Funding: Principal Investigator for multiple national and provincial-level projects, including Special Funds for Clinical Research, Frontier Technology Development Funds, and Major Innovation Funds.
Educational Reform: Secured a provincial/ministerial-level Key Teaching Reform Fund grant.
Selected Peer-Reviewed Publications
Hong L et al. Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients. NPJ Precis Oncol. 2024;8(1):217. PMID: 39354054
Geng R et al. Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients. Front Immunol. 2023;14:1125876. PMID: 36969245
Liu Y et al. Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma. Lung Cancer. 2023;179:107169. PMID: 37003209
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Yingyi Wang’s expertise relevant to my lung cancer or pulmonary nodule case?
Dr. Wang’s clinical focus includes early- to late-stage lung cancer, precision medicine, targeted therapy, immunotherapy and the differential diagnosis of pulmonary nodules. MedBridgeNZ can coordinate a remote specialist-review pathway before you travel. We organize your diagnostic reports, imaging, prior treatment history and questions, coordinate translation where needed, and transfer the authorized record set to the relevant PUMCH office. Once the review pathway is confirmed, Dr. Wang will review the submitted materials and provide specialist feedback, recommendations and answers to your questions, helping clarify whether an in-person pathway in Beijing should be considered.
How can an international patient request an appointment with Dr. Wang at PUMCH?
Appointments with senior specialists at PUMCH can be difficult to arrange because of high domestic demand. MedBridgeNZ coordinates the appointment request process, including record preparation, translation, client-authorized document transfer and communication with the relevant hospital office. The process generally begins with a pre-travel specialist review. Once the review pathway is confirmed, Dr. Wang will review the submitted records and respond to the patient’s key questions. After specialist feedback is received, we assist with subsequent appointment communication and scheduling based on the hospital’s response and available arrangements; appointment timing is not guaranteed.
What practical support does MedBridgeNZ provide for oncology care in Beijing?
MedBridgeNZ coordinates the non-clinical framework of the trip, including hospital appointment requests, medical-record preparation, translation coordination, medical invitation or visa-document support, travel and accommodation planning, and non-clinical bilingual administrative assistance in Beijing. We do not provide medical advice, diagnosis or treatment; specialist opinions and clinical decisions are provided by Dr. Wang and the relevant PUMCH team. Hospital, specialist and travel costs remain separate from MedBridgeNZ’s coordination fees unless expressly stated in writing.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking oncology specialist pathways in Beijing, including pathways involving Dr. Yingyi Wang at PUMCH. We coordinate appointment requests, medical-record preparation, translation, client-authorized document transfer, medical invitation or visa-document support, travel planning and non-clinical bilingual administrative assistance. We do not provide medical advice, diagnosis or treatment; clinical opinions and care decisions are provided by the relevant licensed specialist or hospital. Hospital, specialist and travel costs remain separate from MedBridgeNZ’s coordination fees unless expressly stated in writing.